enGene Therapeutics Inc.

ENGN · ENGNW · Biological Products, (No Disgnostic Substances)

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • ENGN · 29286X101 - Common Shares
  • ENGNW · 29286M113 - *W EXP 10/31/202
  • ENGN · 29286M105 - Common Shares
  • ENGNW · 29286X119 - *W EXP 10/31/202
  • ENGN · 46429B226 - INDS BD ETF
Company details and SEC sources

CIK 0001980845 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
ENGN, ENGNW on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
Business address
4868 Rue Levy, Suite 220, Saint Laurent
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
Canada (Federal Level)
Fiscal year end
31 October
Former names on EDGAR
enGene Holdings Inc. (to 09 Mar 2026)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .